Skip to Main Content
Phase III

Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)

  • Study HIC#:2000027269
  • Last Updated:01/01/0001

PACeS is a trial to study most effective treatment for patients who may experience atrial fibrillation after cardiac surgery, particularly coronary artery bypass grafting (CABG). Atrial fibrillation, or Afib (AF), is an irregular heart rhythm. In some cases, AF can cause blood clots. There are currently 2 classes of drugs for preventing blood clots in patients with AF. Antiplatelets, like aspirin, and anticoagulants, or blood thinners. This study aims to determine whether the addition of blood thinners to antiplatelets will improve treatment outcomes in patients who develop AF after CABG.

  • Age18 years and older
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Marianne McCarthy

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Eligibility Criteria

Eligibility Criteria:

Any patient over 18 years of age who experiences a post-CABG episode of AF.

Principal Investigator

For more information about this study, including how to volunteer, contact: